Bildkälla: Stockfoto

Curasight: Brain cancer first indication for uTREAT - Redeye

Redeye gives a short comment on yesterday’s news that Curasight has announced brain cancer as the first indication for uTREAT.

Redeye gives a short comment on yesterday’s news that Curasight has announced brain cancer as the first indication for uTREAT.
Börsvärldens nyhetsbrev
ANNONSER